Olaf Christensen
University of Cologne
Tell me more about Olaf Christensen?
Olaf Christensen is a highly experienced professional with 26.8 years of work experience in clinical development, oncology, clinical trials, and translational medicine. He has a strong academic background with a focus on tumor immunology. Olaf has held various leadership positions in the pharmaceutical industry, including Chief Medical Officer at Orum Therapeutics and Vice President at EMD Serono, Inc. He has also worked as a Group Director at Bristol Myers Squibb and as a Deputy Director of Oncology at Bayer. Olaf's expertise lies in clinical development, oncology, clinical trials, and translational medicine.
For inquiries about Phone Number and Email, please click here Unlock Contact
Emails and Phone Numbers
About
• 14 years of pharmaceutical industry experience in the clinical development of oncology compounds • Over 5 years of clinical oncology experience in the treatment of cancer patients with solid tumors, leukemia, and lymphomas • Program Leader Gastric Ca, Prostate Ca, Paediatric Development, Ipilimumab Phase II-III • Global early clinical development project leader for cancer compounds, leading the early clinical development team including study teams in North America, Europe, and Asia • Responsible for conduct of oncology First in Patient studies, Proof of Concept studies, Phase I studies supporting NDA (QTc, food effect, DDI) • Experienced in IND and IMPD preparations • Representing early clinical development and clinical pharmacology in meetings with health authorities in the US and Europe • Covering translational medicine aspects in close contact with research and preclinical development functions • Strong academic research background with research experience in tumor immunology Specialties: Phase I-IV Clinical Development Oncology Translational Medicine Immuno Oncology
...See MoreWork Experience
Chief Medical Officer
Biotechnology Research
Olaf Christensen's Professional Milestones
- Chief Medical Officer (2021-10-01~): Overseeing and implementing strategic initiatives to enhance patient outcomes and drive efficiency.
- Vice President (2018-12-01~2021-09-01): Driving strategic initiatives, expanding market reach, and achieving exponential profitability throughout the organization.
Education
Medicine
1990-1997Skill
Clinical Development
Oncology
Clinical Trials
Clinical Research
Translational Medicine
Certification
Colleagues
Other Named Olaf Christensen
Frequently asked questions
We found 3 Olaf Christensen's email addresses
Olaf Christensen's social media include: Linkedin,
Olaf Christensen works for Orum Therapeutics
Olaf Christensen's role in Orum Therapeutics is Chief Medical Officer
Olaf Christensen works in the industry of Biotechnology Research
Olaf Christensen's colleagues are Sung Joo Lee,Dennise M Greensmith,Peter Tran
Olaf Christensen's latest job experience is Chief Medical Officer at Orum Therapeutics
Olaf Christensen's latest education in University of Cologne